Q1 EPS Estimates for Abacus Life Boosted by Northland Capmk

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Stock analysts at Northland Capmk lifted their Q1 2025 EPS estimates for shares of Abacus Life in a report issued on Friday, March 28th. Northland Capmk analyst M. Grondahl now expects that the company will post earnings of $0.18 per share for the quarter, up from their prior estimate of $0.15. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life's Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.23 EPS, Q4 2025 earnings at $0.27 EPS and FY2025 earnings at $0.88 EPS.

Abacus Life (NASDAQ:ABL - Get Free Report) last posted its quarterly earnings results on Thursday, March 27th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.03. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The business had revenue of $33.21 million during the quarter, compared to the consensus estimate of $28.76 million.

Separately, B. Riley lowered their price objective on Abacus Life from $17.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $14.30.

Remove Ads

Abacus Life Trading Down 2.1 %

Shares of NASDAQ ABL traded down $0.16 during midday trading on Monday, reaching $7.33. The company had a trading volume of 206,205 shares, compared to its average volume of 143,683. The stock has a market cap of $708.41 million, a PE ratio of -40.72 and a beta of 0.14. Abacus Life has a one year low of $6.75 and a one year high of $12.50. The firm's fifty day moving average price is $7.62 and its 200-day moving average price is $8.26. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65.

Institutional Investors Weigh In On Abacus Life

Institutional investors and hedge funds have recently bought and sold shares of the business. Geneos Wealth Management Inc. purchased a new stake in Abacus Life in the fourth quarter worth about $110,000. Squarepoint Ops LLC purchased a new position in shares of Abacus Life in the 4th quarter valued at approximately $113,000. JPMorgan Chase & Co. boosted its position in shares of Abacus Life by 640.9% during the fourth quarter. JPMorgan Chase & Co. now owns 16,670 shares of the company's stock valued at $131,000 after purchasing an additional 14,420 shares in the last quarter. LPL Financial LLC grew its stake in Abacus Life by 31.0% in the fourth quarter. LPL Financial LLC now owns 23,288 shares of the company's stock worth $182,000 after purchasing an additional 5,507 shares during the period. Finally, XTX Topco Ltd bought a new position in Abacus Life in the fourth quarter worth $193,000.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.